Effect of Subcutaneous Insulin on Spirometric Maneuvers in Patients with Type 1 Diabetes: A Case-Control Study
Authors:
- Enric SánchezESEnric Sánchez
- Chadia MizabCMChadia Mizab
- Ariadna SauretASAriadna Sauret
- Ferran BarbéFBFerran Barbé
- Raquel MartíRMRaquel Martí
- Carolina López-CanoCarolina López-Cano
- Marta HernándezMHMarta Hernández
- Liliana Gutiérrez-CarrasquillaLGLiliana Gutiérrez-Carrasquilla
- Paola CarmonaPCPaola Carmona
- Jessica GonzálezJGJessica González
- Mireia DalmasesMDMireia Dalmases
- Cristina HernándezCHCristina Hernández
Open Access
- 25 April 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (5) , 1249
Abstract
In order to compare spirometric maneuvers in adults according to the presence of type 1 diabetes, a case-control study including 75 patients with type 1 diabetes and 75 controls matched by sex, age, and body mass index were designed. In addition, 75 patients with type 1 diabetes were added to examine the potential the impact of subcutaneous insulin therapy on pulmonary function. Lung function measurements were assessed according to the global initiative for chronic obstructive lung disease guidelines. Basal insulin included long-acting insulin analogues and the delivered background insulin in patients with pump therapy. Bolus insulin included rapid-acting insulin analogues and the delivered insulin to cover postprandial hyperglycemias. Patients with type 1 diabetes showed lower spirometric values in comparison to the control group, together with a higher prevalence of forced expiratory volume in the first second (FEV1) p = 0.044) and restrictive ventilatory pattern (10.7% vs. 0%, p = 0.006) The dose of basal insulin (U/kg/day) showed a negative correlation with forced vital capacity (FVC) (r = −0.205, p = 0.012) and FEV1 (r = −0.182, p = 0.026). The optimal cut-off value for identifying patients with a restrictive spirometric pattern was 0.5 U/kg/day of basal insulin. Additionally, basal insulin (U/kg/day) independently predicted the presence of both a restrictive spirometric pattern (OR = 77.1 (3.2 to 1816.6), p = 0.007) and an abnormal FEV1 (OR = 29.9 (1.5 to 562.8), p = 0.023). In patients with type 1 diabetes, higher basal insulin dosage seems to be related with an impairment of pulmonary function.Keywords
Funding Information
- Instituto de Salud Carlos III (PI12/00803 and PI15/00260)
- European Commission (European Regional Development Fund, Fondo Europeo de Desarrollo Regional, “Una manera de hacer Europa”)
- Menarini Spain S-A (.)
This publication has 35 references indexed in Scilit:
- Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trialDiabetes, Obesity and Metabolism, 2011
- Insulin resistance is related to impaired lung function in morbidly obese women: a case–control studyDiabetes/Metabolism Research and Reviews, 2010
- Association between reduced pulmonary diffusing capacity and cardiac autonomic dysfunction in Type 1 diabetesDiabetic Medicine, 2008
- Cross-Sectional and Prospective Study of Lung Function in Adults With Type 2 DiabetesDiabetes Care, 2008
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Pulmonary Dysfunction in Type 1 Diabetes in Relation to Metabolic Long-Term Control and to Incipient Diabetic NephropathyNephron, 1996
- Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements?Metabolism, 1995
- Pulmonary function in diabetic children with and without persistent microalbuminuriaDiabetes Research and Clinical Practice, 1993
- Insulin receptors and insulin effects on type II alveolar epithelial cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
- Prediction of lean body mass from height and weightJournal of Clinical Pathology, 1966